Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics, Inc. (CGEM) is a healthcare company (biotechnology) based in the United States. The share price is $9.28, down 2.37% on the day, which values the company at $602.14M. Price as of 18 Nov 2026, 11:56 UTC, from Yahoo Finance.

Key facts

Share price
$9.28−2.37% today
Market value
$602.14M
200-week average
$12.7427% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Cullinan Therapeutics, Inc. in more detail

CGEM trades at -4.0× next year's expected earnings. It sits 27% below its 200-week average of $12.74.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Debt is growing faster than cash flow.

Cullinan Therapeutics, Inc. (CGEM): questions and answers

What is Cullinan Therapeutics, Inc.'s market cap?

Cullinan Therapeutics, Inc. is valued at $602.14M at a share price of $9.28.

Is CGEM above its 200-week moving average?

No. CGEM is 27.2% below its 200-week average of $12.74. Long-term investors watch that line because strong companies rarely trade below it for long.

Does CGEM pay a dividend?

Cullinan Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Cullinan Therapeutics, Inc. (CGEM) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/CGEM

Underlying data: Yahoo Finance; company filings with the SEC.